1-9 of 9
Edward A. Neuwelt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial

Etan Orgel, Kristin R. Knight, Yueh-Yun Chi, Jemily Malvar, Teresa Rushing, Victoria Mena, Laurie S. Eisenberg, Shahrad R. Rassekh, Colin J.D. Ross, Erika N. Scott, Michael Neely, Edward A. Neuwelt, Leslie L. Muldoon, David R. Freyer
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (13): 2410–2418.
https://doi.org/10.1158/1078-0432.CCR-23-0252
Published: 05 July 2023
View article titled, Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial
Open the PDF for Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial in another window
Includes: Supplementary data
Journal Articles

Imaging and Therapy with Rituximab Anti-CD20 Immunotherapy in an Animal Model of Central Nervous System Lymphoma

Leslie L. Muldoon, Seth J. Lewin, Edit Dósa, Dale F. Kraemer, Michael A. Pagel, Nancy D. Doolittle, Edward A. Neuwelt
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2207–2215.
https://doi.org/10.1158/1078-0432.CCR-10-2923
Published: 14 April 2011
View article titled, Imaging and Therapy with Rituximab Anti-CD20 Immunotherapy in an Animal Model of Central Nervous System Lymphoma
Open the PDF for Imaging and Therapy with Rituximab Anti-CD20 Immunotherapy in an Animal Model of Central Nervous System Lymphoma in another window
Journal Articles

Sodium Thiosulfate Administered Six Hours after Cisplatin Does Not Compromise Antineuroblastoma Activity

Theresa M. Harned, Ondrej Kalous, Alexander Neuwelt, Jason Loera, Lingyun Ji, Peter Iovine, Richard Sposto, Edward A. Neuwelt, C. Patrick Reynolds
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (2): 533–540.
https://doi.org/10.1158/1078-0432.CCR-06-2289
Published: 25 January 2008
View article titled, Sodium Thiosulfate Administered Six Hours after Cisplatin Does Not Compromise Antineuroblastoma Activity
Open the PDF for Sodium Thiosulfate Administered Six Hours after Cisplatin Does Not Compromise Antineuroblastoma Activity in another window
Journal Articles

Characterization and Magnetic Resonance Imaging of a Rat Model of Human B-Cell Central Nervous System Lymphoma

Carole Soussain, Leslie L. Muldoon, Csanad Varallyay, Kristoph Jahnke, Luciana DePaula, Edward A. Neuwelt
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (8): 2504–2511.
https://doi.org/10.1158/1078-0432.CCR-06-2379
Published: 16 April 2007
View article titled, Characterization and Magnetic Resonance Imaging of a Rat Model of Human B-Cell Central Nervous System Lymphoma
Open the PDF for Characterization and Magnetic Resonance Imaging of a Rat Model of Human B-Cell Central Nervous System Lymphoma in another window
Journal Articles

New Frontiers in Translational Research in Neuro-oncology and the Blood-Brain Barrier: Report of the Tenth Annual Blood-Brain Barrier Disruption Consortium Meeting

Nancy D. Doolittle, Lauren E. Abrey, W. Archie Bleyer, Steven Brem, Thomas P. Davis, Paula Dore-Duffy, Lester R. Drewes, Walter A. Hall, John M. Hoffman, Agnieszka Korfel, Robert Martuza, Leslie L. Muldoon, David Peereboom, Darryl R. Peterson, Samuel D. Rabkin, Quentin Smith, Glen H.J. Stevens, Edward A. Neuwelt
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 421–428.
https://doi.org/10.1158/1078-0432.421.11.2
Published: 08 February 2005
View article titled, New Frontiers in Translational Research in Neuro-oncology and the Blood-Brain Barrier: Report of the Tenth Annual Blood-Brain Barrier Disruption Consortium Meeting
Open the PDF for New Frontiers in Translational Research in Neuro-oncology and the Blood-Brain Barrier: Report of the Tenth Annual Blood-Brain Barrier Disruption Consortium Meeting in another window
Journal Articles

Herstatin, an Autoinhibitor of the Epidermal Growth Factor (EGF) Receptor Family, Blocks the Intracranial Growth of Glioblastoma

Julia A. Staverosky, Leslie L. Muldoon, Shuhua Guo, Adam J. Evans, Edward A. Neuwelt, Gail M. Clinton
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 335–340.
https://doi.org/10.1158/1078-0432.335.11.1
Published: 21 January 2005
View article titled, Herstatin, an Autoinhibitor of the Epidermal Growth Factor (EGF) Receptor Family, Blocks the Intracranial Growth of Glioblastoma
Open the PDF for Herstatin, an Autoinhibitor of the Epidermal Growth Factor (EGF) Receptor Family, Blocks the Intracranial Growth of Glioblastoma in another window
Journal Articles

Targeted Delivery in Primary and Metastatic Brain Tumors: Summary Report of the Seventh Annual Meeting of the Blood-Brain Barrier Disruption Consortium

Nancy D. Doolittle, Lauren E. Abrey, Nicolay Ferrari, Walter A. Hall, Edward R. Laws, Roger E. McLendon, Leslie L. Muldoon, David Peereboom, Darryl R. Peterson, C. Patrick Reynolds, Peter Senter, Edward A. Neuwelt
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1702–1709.
Published: 01 June 2002
View article titled, Targeted Delivery in Primary and Metastatic Brain Tumors: <subtitle>Summary Report of the Seventh Annual Meeting of the Blood-Brain Barrier Disruption Consortium</subtitle>
Open the PDF for Targeted Delivery in Primary and Metastatic Brain Tumors: <subtitle>Summary Report of the Seventh Annual Meeting of the Blood-Brain Barrier Disruption Consortium</subtitle> in another window
Journal Articles

Delayed Sodium Thiosulfate as an Otoprotectant Against Carboplatin-induced Hearing Loss in Patients with Malignant Brain Tumors

Nancy D. Doolittle, Leslie L. Muldoon, Robert E. Brummett, Rose Marie Tyson, Cynthia Lacy, Joseph S. Bubalo, Dale F. Kraemer, Michael C. Heinrich, James A. Henry, Edward A. Neuwelt
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (3): 493–500.
Published: 01 March 2001
View article titled, Delayed Sodium Thiosulfate as an Otoprotectant Against Carboplatin-induced Hearing Loss in Patients with Malignant Brain Tumors
Open the PDF for Delayed Sodium Thiosulfate as an Otoprotectant Against Carboplatin-induced Hearing Loss in Patients with Malignant Brain Tumors in another window
Journal Articles

Delayed Administration of Sodium Thiosulfate in Animal Models Reduces Platinum Ototoxicity without Reduction of Antitumor Activity

Leslie L. Muldoon, Michael A. Pagel, Robert A. Kroll, Robert E. Brummett, Nancy D. Doolittle, Eleanor G. Zuhowski, Merrill J. Egorin, Edward A. Neuwelt
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (1): 309–315.
Published: 01 January 2000
View article titled, Delayed Administration of Sodium Thiosulfate in Animal Models Reduces Platinum Ototoxicity without Reduction of Antitumor Activity
Open the PDF for Delayed Administration of Sodium Thiosulfate in Animal Models Reduces Platinum Ototoxicity without Reduction of Antitumor Activity in another window